Northside Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.92M | Sell |
126,811
-379
| -0.3% | -$30.6K | 0.81% | 41 |
|
|
2026
Q1 | $11M | Sell |
127,190
-3,822
| -3% | -$366K | 0.97% | 34 |
|
|
2025
Q4 | $12.6M | Buy |
131,012
+20,685
| +19% | +$2.01M | 1.09% | 31 |
|
|
2025
Q3 | $10.5M | Buy |
110,327
+88,783
| +412% | +$8.16M | 0.96% | 33 |
|
|
2025
Q2 | $1.88M | Buy |
+21,544
| New | +$1.83M | 0.14% | 76 |
|
|
2023
Q4 | – | Sell |
-6,747
| Closed | -$529K | – | 123 |
|
|
2023
Q3 | $529K | Hold |
6,747
| – | – | 0.12% | 53 |
|
|
2023
Q2 | $594K | Hold |
6,747
| – | – | 0.21% | 47 |
|
|
2023
Q1 | $544K | Hold |
6,747
| – | – | 0.15% | 51 |
|
|
2022
Q4 | $524K | Buy |
6,747
+234
| +4% | +$19K | 0.16% | 53 |
|
|
2022
Q3 | $526K | Hold |
6,513
| – | – | 0.17% | 51 |
|
|
2022
Q2 | $585K | Hold |
6,513
| – | – | 0.18% | 46 |
|
|
2022
Q1 | $723K | Hold |
6,513
| – | – | 0.19% | 46 |
|
|
2021
Q4 | $674K | Hold |
6,513
| – | – | 0.18% | 46 |
|
|
2021
Q3 | $816K | Hold |
6,513
| – | – | 0.22% | 47 |
|
|
2021
Q2 | $808K | Hold |
6,513
| – | – | 0.2% | 47 |
|
|
2021
Q1 | $769K | Hold |
6,513
| – | – | 0.21% | 46 |
|
|
2020
Q4 | $763K | Hold |
6,513
| – | – | 0.23% | 45 |
|
|
2020
Q3 | $677K | Sell |
6,513
-1,115
| -15% | -$112K | 0.22% | 46 |
|
|
2020
Q2 | $699K | Buy |
7,628
+3,005
| +65% | +$288K | 0.24% | 48 |
|
|
2020
Q1 | $417K | Sell |
4,623
-1,050
| -19% | -$112K | 0.2% | 49 |
|
|
2019
Q4 | $644K | Hold |
5,673
| – | – | 0.22% | 44 |
|
|
2019
Q3 | $616K | Buy |
+5,673
| New | +$592K | 0.22% | 45 |
|
|
2017
Q2 | – | Sell |
-5,776
| Closed | -$465K | – | 98 |
|
|
2017
Q1 | $465K | Buy |
5,776
+2,800
| +94% | +$219K | 0.13% | 93 |
|
|
2016
Q4 | $212K | Hold |
2,976
| – | – | 0.08% | 59 |
|
|
2016
Q3 | $257K | Hold |
2,976
| – | – | 0.1% | 57 |
|
|
2016
Q2 | $258K | Hold |
2,976
| – | – | 0.12% | 59 |
|
|
2016
Q1 | $223K | Sell |
2,976
-65
| -2% | -$4.9K | 0.14% | 61 |
|
|
2015
Q4 | $234K | Sell |
3,041
-41,662
| -93% | -$3.14M | 0.18% | 39 |
|
|
2015
Q3 | $2.99M | Hold |
44,703
| – | – | 2.28% | 6 |
|
|
2015
Q2 | $3.31M | Hold |
44,703
| – | – | 2.23% | 6 |
|
|
2015
Q1 | $3.49M | Hold |
44,703
| – | – | 2.37% | 3 |
|
|
2014
Q4 | $3.23M | Buy |
+44,703
| New | +$3.11M | 2.32% | 4 |
|
Other funds holding MDT
Northside Capital Management's MDT Position: Q2 2026 in Review
Northside Capital Management reduced its Medtronic (MDT) stake by 0.3% in Q2 2026, selling an estimated $30.6K and leaving 126,811 shares worth $9.92M. The position accounts for 0.81% of the portfolio, ranked #41.
Northside Capital Management first reported a position in MDT in Q4 2014 and has held it in 32 quarters since. The position peaked at $12.6M in Q4 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Northside Capital Management held 126,811 shares of Medtronic worth $9.92M as of Q2 2026.
- Northside Capital Management sold 379 Medtronic shares in Q2 2026, an estimated $30.6K.
- Medtronic made up 0.81% of Northside Capital Management's portfolio in Q2 2026, its #41 holding.
- Northside Capital Management first reported a position in Medtronic in Q4 2014 and has held it in 32 quarters since.
- Northside Capital Management's Medtronic position peaked at $12.6M in Q4 2025.
- 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Northside Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.